Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity

被引：0
|
作者：
Wood, S. [1 ]
Li, R. [1 ]
Beesley, S. [1 ]
Brown, J. [1 ]
Cominos, M. [1 ]
Hall, J. [1 ]
Sevitt, T. [1 ]
Shah, R. [1 ]
Taylor, H. [1 ]
Burcombe, R. [1 ]
机构：
[1] Maidstone Hlth Author, Oncol, Maidstone, Kent, England
来源：
LUNG CANCER | 2015年 / 87卷
关键词：
D O I：
10.1016/S0169-5002(15)50065-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [11] IALT-Bio:: a challenging research to improve adjuvant chemotherapy of completely resected NSCLC
    Pirker, Robert
    Filipits, Martin
    Dunant, Ariane
    Pignon, Jean-Pierre
    Soria, Jean-Charles
    Brambilla, Elisabeth
    Popper, Helmut
    Andre, Fabrice
    Stahel, Rolf
    Le Chevalier, Thierry
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S397 - S398
  • [12] Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
    Katsurada, Naoko
    Tachihara, Motoko
    Hatakeyama, Yukihisa
    Koyama, Kiyoko
    Yumura, Masako
    Kiriu, Tatsunori
    Dokuni, Ryota
    Hazama, Daisuke
    Tokunaga, Shuntaro
    Tamura, Daisuke
    Nakata, Kyosuke
    Yamamoto, Masatsugu
    Kamiryo, Hiroshi
    Kobayashi, Kazuyuki
    Tanaka, Yugo
    Maniwa, Yoshimasa
    Nishimura, Yoshihiro
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 777 - 782
  • [13] ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES
    Ramsden, K.
    Laskin, J.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S31 - S32
  • [14] Review of practice patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer (NSCLC)
    Visbal, A
    Kassam, F
    Johnston, M
    Feld, R
    Shepherd, F
    Darling, G
    Keshavjee, S
    Pierre, A
    Waddell, T
    Leighl, N
    LUNG CANCER, 2005, 49 : S97 - S97
  • [15] Adjuvant Chemotherapy With Modified Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC: Survival Analysis of FAST-Nab.
    Saji, H.
    Sakai, H.
    Kimura, H.
    Miyazawa, T.
    Marushima, H.
    Kojima, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S243 - S243
  • [16] Adjuvant chemotherapy for NSCLC: Experience from one cancer centre
    Smith, T.
    Kanani, R.
    Turner, B.
    Dickson, J.
    LUNG CANCER, 2017, 103 : S33 - S34
  • [17] Adjuvant chemotherapy in completely resected non-small-cell lung cancer
    Pisters, KMW
    Le Chevalier, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3270 - 3278
  • [18] Adjuvant Chemotherapy for Completely Resected Non-Small-Cell Lung Cancer
    Suehisa, Hiroshi
    Toyooka, Shinichi
    ACTA MEDICA OKAYAMA, 2009, 63 (05) : 223 - 230
  • [19] Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer
    He, Jiaxi
    Shen, Jianfei
    Yang, Chenglin
    Jiang, Long
    Liang, Wenhua
    Shi, Xiaoshun
    Xu, Xin
    He, Jianxing
    MEDICINE, 2015, 94 (22) : e903
  • [20] A Feasibility Study of Adjuvant Chemotherapy with Modified Weekly Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC
    Saji, Hisashi
    Sakai, Hiroki
    Kimura, Yukihiro
    Miyazawa, Tomoyuki
    Nakamura, Haruhiko
    Marushima, Hideki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S931 - S932
12345